MA decreases in the presence of platelet anti-aggregants or marked thrombocytopenia, and increases in the case of platelet hyper-aggregation.
Disminuye en presencia de antiagregantes plaquetarios o trombocitopenia marcada, y aumenta en hiperagregabilidad plaquetaria.